HomeNews

Anthropic Acquires AI Biotech Startup Coefficient Bio in $400M Deal to Revolutionize Drug Discovery

Andrew LeeAndrew Lee1h ago

Anthropic Acquires AI Biotech Startup Coefficient Bio in $400M Deal to Revolutionize Drug Discovery

Image Copyright: Krisztian Bocsi/Bloomberg / Getty Images.

Anthropic has acquired Coefficient Bio, a stealth biotech AI startup, in a $400 million stock deal reported on April 3, 2026.

This move accelerates Anthropic's expansion into healthcare and life sciences.

Company Backgrounds

Anthropic, renowned for its AI models, launched Claude for Life Sciences last October to support scientific breakthroughs.

Coefficient Bio was founded eight months ago by ex-Genentech researchers Samuel Stanton and Nathan C. Frey.

The startup's team of about 10 focused on AI tools to streamline drug discovery and biological research.

Strategic Acquisition Reasons

The deal bolsters Anthropic's expertise in applying AI to biotech challenges like efficient drug development.

Coefficient Bio's team will join Anthropic’s health and life sciences group for seamless integration.

Broader Impacts and Future

This acquisition highlights the growing convergence of AI and biotech, promising faster innovations in medicine.

Historically, such AI-biotech mergers have reduced drug development timelines and costs significantly.

Looking forward, Anthropic could lead in AI-driven personalized therapies and novel treatments.

The biotech industry anticipates transformative changes from this high-profile union.

Article Details

Author / Journalist:

Category: StartupsBusiness

Markets:

Topics:

Source Website Secure: No (HTTP)

News Sentiment: Neutral

Fact Checked: Legitimate

Article Type: News Report

Published On: 2026-04-03 @ 20:28:40 (1 hours ago)

News Timezone: GMT -5:00

News Source URL: beamstart.com

Language: English

Platforms: Desktop Web, Mobile Web, iOS App, Android App

Copyright Owner: © TechCrunch

News ID: 30730408

About TechCrunch

TechCrunch Logo

Main Topics: StartupsBusiness

Official Website: techcrunch.com

Update Frequency: 2 posts per day

Year Established: 2005

Headquarters: United States

Coverage Areas: United States

Ownership: Independent Company

Publication Timezone: GMT -5:00

Content Availability: Worldwide

News Language: English

RSS Feed: Available (XML)

API Access: Available (JSON, REST)

Website Security: Secure (HTTPS)

Publisher ID: #1

Frequently Asked Questions

Which news outlet covered this story?

The story "Anthropic Acquires AI Biotech Startup Coefficient Bio in $400M Deal to Revolutionize Drug Discovery" was covered 1 hours ago by TechCrunch, a news publisher based in United States.

How trustworthy is 'TechCrunch' news outlet?

TechCrunch is a fully independent (privately-owned) news outlet established in 2005 that covers mostly startups and business news.

The outlet is headquartered in United States and publishes an average of 2 news stories per day.

What do people currently think of this news story?

The sentiment for this story is currently Neutral, indicating that people are not responding positively or negatively to this news.

How do I report this news for inaccuracy?

You can report an inaccurate news publication to us via our contact page. Please also include the news #ID number and the URL to this story.
  • News ID: #30730408
  • URL: https://beamstart.com/news/anthropic-buys-biotech-startup-coefficient-1775248

BEAMSTART

BEAMSTART is a global entrepreneurship community, serving as a catalyst for innovation and collaboration. With a mission to empower entrepreneurs, we offer exclusive deals with savings totaling over $1,000,000, curated news, events, and a vast investor database. Through our portal, we aim to foster a supportive ecosystem where like-minded individuals can connect and create opportunities for growth and success.

Connect with Us

Discover More

© Copyright 2026 BEAMSTART. All Rights Reserved.